In 2017, the legal department at Ortho Clinical Diagnostics played a key role in the evolution of the $1.8 billion in vitro diagnostics company, acquiring a Brazil operation and completing a three-year process of transitioning to private equity ownership from former parent company Johnson & Johnson. The group handled various other matters, including negotiation of a $200 million credit line increase and preparation for the European Union’s General Data Protection Regulation. Three of the Ortho legal department’s eight lawyers, and 14 of its 22 total professionals, are based in Raritan.

** The responses were provided by Michael Schlesinger, executive vice president, general counsel and secretary at Ortho Clinical Diagnostics. **

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]